← Back to Search

Behavioural Intervention

Blood Flow Restriction Training for Grip Strength

N/A
Recruiting
Research Sponsored by Casa Colina Hospital and Centers for Healthcare
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must be between 18 and 35 years old at the time of enrollment
Participants should be in good general health with no known cardiovascular, musculoskeletal, or neurological disorders that could interfere with exercise participation
Must not have
Participants with a history of cardiovascular disease (e.g., heart disease, hypertension), musculoskeletal injuries (e.g., fractures, dislocations), or neurological disorders (e.g., neuropathy) that could affect exercise performance will be excluded
Participants taking medications or supplements that may impact muscle strength, metabolism, or blood flow will be excluded from the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post-intervention (6 weeks), and follow-up (6 weeks)
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare the effects of Blood Flow Restriction (BFR) training with traditional low-weight resistance training on grip strength in young adults. There is limited research on the impact of BFR

Who is the study for?
This trial is for healthy young adults interested in improving their grip strength. Participants should be willing to undergo Blood Flow Restriction (BFR) training or traditional low-weight resistance training.
What is being tested?
The study aims to compare the effectiveness of BFR training versus traditional resistance exercises on enhancing grip strength in participants, contributing valuable data on this fitness technique.
What are the potential side effects?
Potential side effects from BFR training may include discomfort, bruising, numbness, or temporary muscle fatigue due to restricted blood flow during exercise.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 35 years old.
Select...
I am in good health with no heart, muscle, or nerve conditions that affect exercise.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have heart disease, high blood pressure, serious injuries, or nerve disorders that could affect my ability to exercise.
Select...
I am not on medications or supplements that affect muscle strength, metabolism, or blood flow.
Select...
I have no recent injuries to my arms or hands.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post-intervention (6 weeks), and follow-up (6 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-intervention (6 weeks), and follow-up (6 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Grip Strength

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Blood flow restriction with low-weight resistance training (LWRT) groupExperimental Treatment1 Intervention
a blood flow restriction with low-weight resistance training (LWRT) group
Group II: No Blood flow restriction group which just does LWRTActive Control1 Intervention
a non blood flow restriction group which just does low-weight resistance training

Find a Location

Who is running the clinical trial?

Casa Colina Hospital and Centers for HealthcareLead Sponsor
10 Previous Clinical Trials
305 Total Patients Enrolled
Azusa Pacific UniversityOTHER
4 Previous Clinical Trials
159 Total Patients Enrolled
~27 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top